IVUS Catheters Market
Number of pages: 100 | Report Format: PDF | Published date: April 10, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 627.1 million |
|
Revenue Forecast in 2031 |
US$ 1,143.1 million |
|
CAGR |
6.9% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Modality, Type, indication, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global IVUS catheters market was valued at US$ 627.1 million in 2022 and is expected to register a revenue CAGR of 6.9% to reach US$ 1,143.1 million by 2031.
IVUS Catheters Market Fundamentals
Intravascular ultrasound (IVUS) catheter examines blood vessel tissue by inserting a small tube into the blood vessel. With the help of a non-invasive diagnostic procedure, IVUS, medical professionals can precisely identify and treat cardiovascular diseases by obtaining clear images of the interior of the blood vessels. Cardiology has undergone a revolution owing to this technology, which is now a crucial instrument for interventional cardiologists treating and diagnosing coronary artery disease.
Invasive coronary angiography is currently the gold standard for the detection of atherosclerosis. The best imaging technique for assessing coronary arteries so far is IVUS imaging. High-resolution images of the arterial wall and lumen are provided by smaller IVUS catheters diameter, enabling precise evaluation of plaque burden and composition. It is an effective tool for assisting patients with coronary artery disease in making treatment choices. IVUS catheter offers adequate spatial resolution and penetration depth for accurately visualizing coronary artery anomalies compared to other intravascular imaging modalities.
Additionally, the IVUS catheters approach a cross-sectional view of the arterial wall in real-time, complete with morphological and pathological traits. IVUS procedure has been clinically validated for a long time and has not been associated with any known short or long-term side effects. For IVUS procedure applications, a variety of ultrasound transducer advancements have been described recently. As a result of these developments, image quality, and clinical utility have improved, making IVUS imaging a crucial instrument in the detection and management of coronary artery disease. IVUS catheters are expected to play a bigger part in treating cardiovascular disease as technology progresses.
[97854]
IVUS Catheters Market Dynamics
As heart diseases spread worldwide, there is a growing need for non-invasive and precise diagnostic methods. Due to their accuracy and safety, non-invasive diagnostic techniques like IVUS catheters are becoming increasingly widespread. These techniques also aid in the early detection of heart conditions, which can improve the effectiveness of therapy. IVUS catheters offer better accuracy, less invasiveness, and real-time monitoring. As a result, the use of these catheters in treating cardiovascular diseases is increasing. The World Health Organization (WHO) reports that cardiovascular illnesses are the main reason for mortality worldwide. About 17.9 million people died from these diseases in 2019, 32% of all deaths globally.
Furthermore, heart attacks and strokes accounted for 85% of these fatalities. Therefore, it is expected that the market revenue for IVUS catheters will be trending in the near future due to the rising prevalence of cardiovascular diseases. The adoption of IVUS catheters in healthcare facilities around the world is because of the rising prevalence of cardiovascular diseases and the demand for efficient diagnostic and therapeutic options. IVUS catheters allow medical workers to precisely identify and treat cardiovascular diseases, lowering the mortality rates related to these illnesses.
IVUS catheters are minimally invasive. Patients can recover more rapidly as a result, and complications are less likely to occur. IVUS catheters produce finely detailed images of the interior of blood vessels using high-frequency sound waves, enabling medical professionals to identify and address conditions like plaque buildup or blockages. Cardiology has revolutionized due to this technology, which is now widely used in hospitals worldwide. Instead of large, open incisions, small punctures or incisions are used to conduct minimally invasive procedures. While still getting the desired medical results, these procedures help lessen the amount of tissue damage and scarring during conventional open surgeries.
However, reusing disposable IVUS catheters is a major issue preventing the growth of the global IVUS catheter market. In addition to endangering patient safety, this issue raises the price of healthcare. Reusing disposable IVUS catheters raise the danger of infections spreading and compromises patient security. Furthermore, because patients might need additional treatment for infections brought on by contaminated catheters, it increases the financial strain on healthcare systems. Therefore, creating affordable and secure substitutes for throwaway IVUS catheters could aid in resolving these problems and advancing eco-friendly medical procedures.
IVUS Catheters Market Ecosystem
This report provides the global IVUS catheters market analysis in terms of revenue, market dynamics, regional landscape, and overall competitive positioning of the major market players. The global IVUS catheters market is analyzed from five perspectives: modality, type, indication, end-user, and region.
IVUS Catheters Market by Modality
[12345]
Based on the modalities, the global IVUS catheters market is segmented into virtual histology IVUS, iMap IVUS, and integrated backscatter IVUS.
The virtual histology IVUS segment accounted for the largest revenue share of the global IVUS catheters market in 2022. Virtual histology is a recent and significant advancement in the IVUS catheters market, completely changing the caliber and understanding of intravascular ultrasound imaging. Virtual histology intravascular ultrasound (VHIVUS) is a catheter-based technology in which IVUS is produced from the transducer on the catheter tip. The reflected signals from the artery wall produce a color-coded map of the arterial disease. The interventionist can better predict how the lesion will respond to treatment by using this color-coded map to determine whether it will completely defy stent deployment or be susceptible to embolization. Virtual histology IVUS is now used in peripheral circumstances after being initially developed for coronary interventions. Its ability to increase the safety and effectiveness of carotid endoluminal repair generates significant interest because it offers a detailed and up-close view of plaque. Virtual histology IVUS catheter-based invasive diagnosis can differentiate between various plaque kinds. It can identify plaque risk indicators. Virtual histology IVUS catheter is used in various peripheral circumstances in addition to coronary interventions. It is a promising tool for enhancing the security and effectiveness of carotid endoluminal repair due to its capacity to provide a detailed and up-close look at the plaque.
IVUS Catheters Market by Type
Based on the types, the global IVUS catheters market is segmented into mechanical IVUS catheters, solid-state IVUS catheters, digital IVUS catheters, and others.
The mechanical IVUS catheters segment accounted for the largest revenue share of the global IVUS catheters market in 2022. The mechanical IVUS transducer obtains the vascular cross-sectional image by 360° rotation with more than 1800 rpm. Therefore it can form an image with only a single element. As a result, the mechanical IVUS transducers are small, enabling critical procedures and thus minimizing an IVUS catheter diameter in which the transducer is rotated to generate and receive ultrasound. The high rotational speed of the mechanical IVUS transducer also allows for real-time imaging during catheterization procedures, providing valuable information to clinicians. This technology has revolutionized the diagnosis and treatment of cardiovascular diseases by allowing for precise visualization of the arterial walls and detecting any abnormalities.
IVUS Catheters Market by Indication
Based on the indications, the global IVUS catheters market is segmented into aortic aneurysms, blood clots, coronary artery diseases, and deep vein thrombosis.
The coronary artery disease segment accounted for the largest revenue share of the global IVUS catheters market in 2022. Due to the increasing prevalence, consequences for mortality and disability, and significant financial burden, coronary artery diseases rank among the leading cause of concern. One-third of all fatalities globally are attributable to coronary artery disease, with low- and middle-income countries disproportionately affected. The World Health Organization estimates that 17.9 million deaths worldwide occur yearly due to cardiovascular disease, which will more than double to 23.6 million by 2030. To lessen the impact of cardiovascular disease on individuals and society, it is essential to adopt preventive measures, efficient treatment approaches, and sophisticated diagnostic approaches. In individuals with coronary artery disease, intravascular imaging helps determine the severity of the stenosis and in directing percutaneous coronary intervention. Using a minimum lumen size determined by IVUS as a revascularization cutoff has been suggested. Due to the smaller IVUS catheter diameter, intravascular ultrasound imaging provided positive results for coronary artery disorders. Furthermore, due to its better resolution and capacity to see plaque morphology, IVUS catheter has been growing in popularity. These imaging methods can help with the early diagnosis and treatment of coronary artery disease, eventually improving patient outcomes.
IVUS Catheters Market by End User
Based on the end users, the global IVUS catheters market is segmented into hospitals, ambulatory surgical centers, diagnostic imaging centers, and others.
The hospital's segment accounted for the largest revenue share of the global IVUS catheters market in 2022. Angiography, electrophysiology tests, and other catheter-based tests to diagnose cardiovascular diseases frequently receive care in hospitals as their main healthcare facilities. Suppose a patient's primary care physician suspects a cardiovascular problem. In that case, they may be directed to hospitals for these tests, which support the demand of the global IVUS catheter market. Hospitals offer a variety of treatment choices for cardiovascular diseases, including prescription drug management, surgical interventions, cardiac rehabilitation programs, and diagnostic tests and procedures such as IVUS catheters. Hospitals are crucial for managing complex cardiovascular conditions and offering patients complete healthcare because they offer a broad range of medical services, such as emergency care, surgery, and inpatient care. Only hospitals provide inpatient surveillance and treatment, which is required for some diagnostic procedures such as IVUS catheters. This covers procedures for patients with complicated cardiovascular issues or needing careful monitoring and post-procedure care. Because they have enough funding for cutting-edge diagnostics equipment, hospitals can effectively conduct cardiovascular diagnostics. Hospitals also have a group of highly skilled medical workers, such as cardiologists, nurses, and technicians, who focus on cardiovascular care. Due to this knowledge, patients are guaranteed to receive the finest care and remedies for their cardiovascular conditions. Additionally, hospitals frequently have specialized cardiac care facilities with knowledgeable personnel and cutting-edge equipment to offer patients optimum care for complex cardiovascular conditions and IVUS catheter handling. This overall results in the segment's revenue growth.
IVUS Catheters Market by Region
Based on the regions, the global IVUS catheters market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounted for the largest revenue share of the global IVUS Catheters market in 2022. This is ascribed to a high prevalence of chronic diseases, high healthcare spending, and advanced healthcare infrastructure. Additionally, the nation strongly focuses on health education and preventive healthcare initiatives that lessen the weight of chronic diseases. The government also invests significant money in research and development to improve medical procedures and treatments. Increased healthcare spending has also made it feasible to have modern medical facilities and trained medical personnel. This results in regional revenue expansion.
Competitive Landscape of the Global IVUS Catheters Market
Notable market participants Operating in the global IVUS market with the largest share include:
Strategic Development in IVUS Catheters Market
Intravascular ultrasound (IVUS) is a catheter-based diagnostic procedure used to view the inside of a coronary artery, providing a real-time view.
The increased prevalence of cardiovascular diseases and increased demand for advanced diagnostics are the key factors driving the revenue of the global IVUS catheter market.
The high cost and complications are restraining the revenue growth of the global IVUS catheters market to its full potential.
Key companies operating the global IVUS catheters market are Abbott, ACIST Medical Systems, Boston Scientific Corporation, Cook Medical, and Cordis.
The global IVUS catheters market is expected to register a revenue CAGR of 6.9% during the forecast period from 2023 to 2031.
*Insights on financial performance are subject to the availability of information in the public domain